Bond.az White LogoBond.az Black Logo

Compass Inc. SWOT analysis: stock eyes growth after acquisition

Compass Inc. SWOT analysis after HOUS acquisition. Analyst projections, financial performance, growth prospects, and key risks.

Sophia Anderson
BySophia Anderson- Senior Editor
|
0

Compass Inc. has undergone a significant transformation, completing the acquisition of HOUS. Analysts believe this could reshape its position in residential real estate brokerage.

Analysts raised the price target by about 67% and upgraded the stock rating. The stock trades at $8.40 with a market cap of approximately $6.28 billion.

The HOUS acquisition provides Compass with unprecedented scale and market share. Revenue grew 40.1% over the last twelve months, though gross profit margin remains modest at 13%.

Financial projections show EBITDA compound annual growth of 35% from 2025 to 2027. EPS is expected to be -$0.10 in the first fiscal year and $0.06 in the second.

Market capitalization expanded from $4.48 billion in November 2025 to $9.07 billion by January 2026, reflecting optimism about the strategic direction.

Compass operates as a technology-first brokerage. Despite macroeconomic headwinds, the company leverages scale advantages to pursue growth.

Integration risks include agent retention and technology consolidation. Analysts upgraded the rating from Equal Weight to Overweight, with a price target increase from $9 to $15.

The long-term outlook suggests scale advantages compound over time. The 35% EBITDA growth target is ambitious but achievable with successful integration.

More News
Today / 19:40
|
859

HCA Healthcare SWOT analysis: stock gains momentum on guidance

HCA Healthcare SWOT analysis: stock potential, revenue guidance, and risks. Insights on SDP programs, ACA subsidies, and efficiency initiatives.

0
Today / 18:50
|
343

Prosperity Bancshares SWOT: stock faces growth headwinds

SWOT analysis of Prosperity Bancshares: acquisition strategy, loan growth challenges, asset quality, and earnings outlook.

0
Today / 18:30
|
683

Kura Sushi USA SWOT Analysis: Stock Faces Comp Headwinds

Kura Sushi USA SWOT analysis: Stock faces comparable sales headwinds but benefits from expansion and labor efficiency. Detailed on Bond.az.

0
Today / 18:10
|
896

First Watch SWOT analysis: stock faces breakfast challenges

SWOT analysis of First Watch Restaurant Group: breakfast segment challenges, expansion potential, and financial metrics. Comprehensive analysis by Bond.az.

0
Today / 17:40
|
706

Lincoln Electric SWOT Analysis: Stock Navigates Industrial Recovery

SWOT analysis of Lincoln Electric: industrial recovery, pricing strategies, automation potential, and stock valuation insights.

0
Today / 17:21
|
452

Impinj SWOT: inventory correction and outlook

SWOT analysis of Impinj stock: inventory correction, BLE complementary technology, and grocery retail growth opportunities.

0
Today / 17:01
|
351

Old Dominion SWOT: stock navigates freight downturn

Old Dominion Freight Line SWOT analysis: How is the stock navigating the freight downturn? Strengths, weaknesses, opportunities, and threats for ODFL. Detailed financial analysis on Bond.az.

0
Today / 16:40
|
298

FIBK under balance sheet pressure

First Interstate BancSystem (FIBK) faces balance sheet pressure and weak loan production, leading analysts to cut earnings estimates. Shares may be undervalued.

0
Today / 16:20
|
736

KLA SWOT Analysis: Growth Prospects

SWOT analysis of KLA Corporation: growth prospects, conservative outlook, and market position in the semiconductor equipment industry.

0
Today / 16:10
|
499

Republic Services SWOT: Stock Balances Margin Strength, Revenue Woes

Republic Services (RSG) SWOT analysis: margin strength vs revenue concerns. Pricing power and operational efficiency drive stock performance.

0
Today / 15:50
|
476

Qorvo SWOT analysis: semiconductor stock on merger path

Qorvo SWOT analysis: strengths, weaknesses, opportunities, and threats for the semiconductor stock as it navigates the merger with Skyworks Solutions.

0
Today / 15:20
|
807

Kura Oncology SWOT Analysis: Launch Test

Kura Oncology SWOT analysis: FDA approval, early sales results, and future prospects for this biotech stock.

0
...
Compass Inc. SWOT analysis: stock eyes growth after acquisition | Bond.az